向卫生专业人员开展有关药品和器械促销的教育：倡导者的建议。
Educating health professionals about drug and device promotion: advocates' recommendations.
作者信息
Mansfield Peter R, Lexchin Joel, Wen Leana S, Grandori Luisella, McCoy Christopher P, Hoffman Jerome R, Ramos Joana, Jureidini Jon N
机构信息
Healthy Skepticism Inc., Willunga, Australia.
出版信息
PLoS Med. 2006 Nov;3(11):e451. doi: 10.1371/journal.pmed.0030451.
Abstract
Mansfield and colleagues outline the recommendations from four advocacy groups for improving the education of health professionals on promotion of drugs and devices.
摘要
曼斯菲尔德及其同事概述了四个倡导团体提出的关于改善卫生专业人员在药品和器械推广方面教育的建议。
相似文献
1
Educating health professionals about drug and device promotion: advocates' recommendations.向卫生专业人员开展有关药品和器械促销的教育：倡导者的建议。
PLoS Med. 2006 Nov;3(11):e451. doi: 10.1371/journal.pmed.0030451.
2
Educating health professionals about drug and device promotion: a Nepalese perspective.从尼泊尔视角看对卫生专业人员进行药品和器械推广方面的教育
PLoS Med. 2007 Feb;4(2):e89; author reply e88. doi: 10.1371/journal.pmed.0040089.
3
Promotion of drugs and devices at international conferences held in Canada.在加拿大举办的国际会议上推广药品和器械。
Health Law Can. 2009 Oct;30(1):16-8.
4
Relationships with the drug industry: More regulation, greater transparency.与制药行业的关系：加强监管，提高透明度。
BMJ. 2009 Feb 3;338:b211. doi: 10.1136/bmj.b211.
5
Educating health care professionals to care for patients with disabilities.培训医疗保健专业人员以照顾残疾患者。
JAMA. 2009 Sep 23;302(12):1334-5. doi: 10.1001/jama.2009.1398.
6
Distance learning for health professionals' education.面向卫生专业人员教育的远程学习。
J Indian Med Assoc. 1997 Jul;95(7):407-9.
7
Getting it right: educating professionals to work together in improving health and health care.
J Interprof Care. 2008 Aug;22(4):364-74. doi: 10.1080/13561820802227871.
8
An educationist teaching healthcare professionals?
Natl Med J India. 2009 May-Jun;22(3):163-4.
9
Transforming health professionals' education.变革卫生专业人员的教育。
Lancet. 2011 Apr 9;377(9773):1237; author reply 1238-9. doi: 10.1016/S0140-6736(11)60498-4.
10
Direct-to-consumer advertising--education or emotion promotion?直接面向消费者的广告——是教育还是情感促销？
N Engl J Med. 2002 Feb 14;346(7):524-6. doi: 10.1056/NEJM200202143460713.
引用本文的文献
1
Assessing the effect of educational intervention on pharmaceutical promotion: a follow-up study among medical students from Pakistan.评估教育干预对药品推广的影响：一项针对巴基斯坦医科学生的随访研究。
BMC Med Educ. 2025 Aug 26;25(1):1199. doi: 10.1186/s12909-025-07725-3.
2
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.基层医疗中的药品营销：直接营销邮件和广告分析。
PLoS One. 2023 Aug 28;18(8):e0290603. doi: 10.1371/journal.pone.0290603. eCollection 2023.
3
A follow-up study on the effects of an educational intervention against pharmaceutical promotion.一项针对药品促销教育干预效果的随访研究。
PLoS One. 2020 Oct 28;15(10):e0240713. doi: 10.1371/journal.pone.0240713. eCollection 2020.
4
Assessment of a Pharmaceutical Advertisement Analysis Module in a Drug Literature Evaluation Course.药物文献评估课程中制药广告分析模块的评估
Am J Pharm Educ. 2017 Aug;81(6):112. doi: 10.5688/ajpe816112.
5
Professionalism perspectives among medical students of a novel medical graduate school in Malaysia.马来西亚一所新型医学院校医学生的职业素养观点
Adv Med Educ Pract. 2016 Jul 25;7:407-22. doi: 10.2147/AMEP.S90737. eCollection 2016.
6
Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.对美国食品药品监督管理局不良广告计划的认知以及关于药品广告的教育：一项针对门诊护理机构开处方者的全国性调查。
J Health Commun. 2015;20(11):1330-6. doi: 10.1080/10810730.2015.1018649. Epub 2015 Jul 15.
7
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.来自制药公司的信息以及医生处方的质量、数量和成本：系统评价。
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
8
A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.一项针对私人执业德国医生与药品销售代表接触情况的调查。
Dtsch Arztebl Int. 2010 Jun;107(22):392-8. doi: 10.3238/arztebl.2010.0392. Epub 2010 Jun 4.
9
"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in Iran.我们注意到，突然间这个国家到处都是 MRI 了。”决策者对伊朗卫生技术的传播和使用的看法。
Health Res Policy Syst. 2010 Apr 6;8:9. doi: 10.1186/1478-4505-8-9.
10
Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research.实施孕期疟疾间歇性预防治疗：前景、成就、挑战及研究议程综述
Open Trop Med J. 2008;1:92-100. doi: 10.2174/1874315300801010092.
本文引用的文献
1
Awareness and attitudes about disease mongering among medical and pharmaceutical students.医学和药学专业学生对疾病贩卖的认知与态度。
PLoS Med. 2006 Apr;3(4):e213. doi: 10.1371/journal.pmed.0030213. Epub 2006 Apr 11.
2
What are the public health effects of direct-to-consumer drug advertising?直接面向消费者的药品广告对公众健康有哪些影响？
PLoS Med. 2006 Mar;3(3):e145. doi: 10.1371/journal.pmed.0030145. Epub 2006 Mar 28.
3
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.引发利益冲突的医疗行业行为：针对学术医疗中心的一项政策提案
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.
4
Banning all drug promotion is the best option pending major reforms.在进行重大改革之前，禁止所有药品促销是最佳选择。
J Bioeth Inq. 2005;2(2):75-81. doi: 10.1007/BF02448846.
5
Pharmacists' perceptions of the pharmaceutical industry.药剂师对制药行业的看法。
Am J Health Syst Pharm. 2005 Nov 15;62(22):2401-9. doi: 10.2146/ajhp050073.
6
Who's buying lunch: are gifts to surgeons from industry bad for patients?谁在买单午餐：行业给外科医生的礼物对患者有害吗？
Thorac Surg Clin. 2005 Nov;15(4):533-42. doi: 10.1016/j.thorsurg.2005.06.004.
7
Medical students' exposure to and attitudes about drug company interactions: a national survey.医学生对制药公司互动的接触情况及态度：一项全国性调查。
JAMA. 2005 Sep 7;294(9):1034-42. doi: 10.1001/jama.294.9.1034.
8
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.制药公司代表来访对基层医疗中抗精神病药物处方的影响。
Schizophr Res. 2005 Sep 1;77(1):107-9. doi: 10.1016/j.schres.2005.02.001.
9
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.制药行业在精神药理学教学中的作用：一个日益严重的问题。
Acad Psychiatry. 2005 May-Jun;29(2):222-9. doi: 10.1176/appi.ap.29.2.222.
10
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.使用环氧化酶2选择性和非选择性非甾体抗炎药治疗的患者发生急性心肌梗死和心源性猝死的风险：巢式病例对照研究
Lancet. 2005;365(9458):475-81. doi: 10.1016/S0140-6736(05)17864-7.
Zotero 插件